Trials / Recruiting
RecruitingNCT06163534
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Tempus AI · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.
Conditions
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2028-03-01
- Completion
- 2028-03-01
- First posted
- 2023-12-11
- Last updated
- 2026-04-06
Locations
30 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT06163534. Inclusion in this directory is not an endorsement.